EC Number |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
---|
3.4.24.19 | Adenocarcinoma |
8700514 |
Characterization of PCP-2, a novel receptor protein tyrosine phosphatase of the MAM domain family. |
ongoing research unassigned |
2 0 |
3.4.24.19 | Adenocarcinoma |
12501215 |
Physical and functional interaction between receptor-like protein tyrosine phosphatase PCP-2 and beta-catenin. |
ongoing research unassigned |
2 0 |
3.4.24.19 | Adenocarcinoma |
17622474 |
Involvement of beta3A subunit of adaptor protein-3 in intracellular trafficking of receptor-like protein tyrosine phosphatase PCP-2. |
ongoing research unassigned |
3 0 |
3.4.24.19 | Adenoma, Pleomorphic |
9532004 |
Expression of bone morphogenetic proteins in salivary pleomorphic adenomas. |
diagnostic usage unassigned |
3 0 |
3.4.24.19 | Alveolar Bone Loss |
33169406 |
Proteinase bone morphogenetic protein 1, but not tolloid-like 1, plays a dominant role in maintaining periodontal homeostasis. |
causal interaction therapeutic application unassigned |
3 1 0 |
3.4.24.19 | Atherosclerosis |
25947382 |
Procollagen C-endopeptidase Enhancer Protein 2 (PCPE2) Reduces Atherosclerosis in Mice by Enhancing Scavenger Receptor Class B1 (SR-BI)-mediated High-density Lipoprotein (HDL)-Cholesteryl Ester Uptake. |
therapeutic application unassigned |
1 0 |
3.4.24.19 | Carcinogenesis |
29024261 |
Pathologic significance of a novel oncoprotein in thyroid cancer progression. |
causal interaction diagnostic usage ongoing research therapeutic application |
3 4 2 1 |
3.4.24.19 | Carcinoma |
9247707 |
Expression of bone morphogenetic proteins of human neoplastic epithelial cells. |
unassigned |
0 |
3.4.24.19 | Carcinoma, Squamous Cell |
9247707 |
Expression of bone morphogenetic proteins of human neoplastic epithelial cells. |
unassigned |
0 |
3.4.24.19 | Colonic Neoplasms |
16574648 |
Protein-tyrosine phosphatase PCP-2 inhibits beta-catenin signaling and increases E-cadherin-dependent cell adhesion. |
therapeutic application unassigned |
1 0 |